Honokiol inhibits the oncogenic KRT18 protein in melanoma and prevents recurrence of advanced melanoma using the β-catenin/MITF axis via prompt calpain-10 and CCAAT homologous protein (CHOP/GADD153) regulated cascades. Here, MITF is linked to melanoma.